共 50 条
- [1] Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 (05): : 313 - 321
- [3] Experience with Cinacalcet in Neonatal Severe Hyperparathyroidism Due to CASR Mutation HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 282 - 282
- [4] Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation (vol 93, pg 313, 2020) HORMONE RESEARCH IN PAEDIATRICS, 2021,
- [6] Calcium sensing receptor gene polymorphism in patients with secondary hyperparathyroidism treated with Cinacalcet PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 297 - 297
- [7] Calcium-sensing by the parathyroids in severe secondary hyperparathyroidism before parathyroidectomy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2675 - A2675
- [8] Cinacalcet for the management of hypercalcemia secondary to calcium-sensing receptor mutation ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (01): : 40 - 41
- [10] Severe Neonatal Hyperparathyroidism Due to a Novel Homozygous Mutation of the Calcium-Sensing Receptor (CaSR) HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 427 - 428